Microbial Determinants of Dementia Risk in Subjects of Mexican Descent with Type 2 Diabetes Living in South Texas

Overview

Journal medRxiv

Date 2024 Apr 2

PMID 38562743

Authors

Lisa M Matz

Nisarg S Shah

Laura Porterfield

Olivia M Stuyck

Michael D Jochum

Rakez Kayed

Giulio Taglialatela

Randall J Urban

Shelly A Buffington

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2D) is a common forerunner of neurodegeneration and dementia, including Alzheimer's Disease (AD), yet the underlying mechanisms remain unresolved. Individuals of Mexican descent living in South Texas have increased prevalence of comorbid T2D and early onset AD, despite low incidence of the predisposing APOE-e4 variant and an absence of the phenotype among relatives residing in Mexico - suggesting a role for environmental factors in coincident T2D and AD susceptibility. Here, in a small clinical trial, we show dysbiosis of the human gut microbiome could contribute to neuroinflammation and risk for AD in this population. Divergent Gastrointestinal Symptom Rating Scale (GSRS) responses, despite no differences in expressed dietary preferences, provided the first evidence for altered gut microbial ecology among T2D subjects (sT2D) population-matched healthy controls (HC). Metataxonomic 16S rRNA sequencing of participant stool revealed a decrease in alpha diversity of sT2D HC gut communities and identified BMI as a driver of gut community structure. Linear discriminant analysis effect size (LEfSe) identified a significant decrease in the relative abundance of the short-chain fatty acid-producing taxa , , and and an increase in pathobionts , , and among sT2D gut microbiota, as well as differentially abundant gene and metabolic pathways. These results suggest characterization of the gut microbiome of individuals with T2D could identify key actors among "disease state" microbiota which may increase risk for or accelerate the onset of neurodegeneration. Furthermore, they identify candidate microbiome-targeted approaches for prevention and treatment of neuroinflammation in AD.

References

Franks P, McCarthy M . Exposing the exposures responsible for type 2 diabetes and obesity. Science. 2016; 354(6308):69-73. DOI: 10.1126/science.aaf5094. View

Santiago-Torres M, Kratz M, Lampe J, de Dieu Tapsoba J, Breymeyer K, Levy L . Metabolic responses to a traditional Mexican diet compared with a commonly consumed US diet in women of Mexican descent: a randomized crossover feeding trial. Am J Clin Nutr. 2016; 103(2):366-74. PMC: 4733259. DOI: 10.3945/ajcn.115.119016. View

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P . The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012; 41(Database issue):D590-6. PMC: 3531112. DOI: 10.1093/nar/gks1219. View

OBryant S, Johnson L, Balldin V, Edwards M, Barber R, Williams B . Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 33(2):373-9. PMC: 3524411. DOI: 10.3233/JAD-2012-121420. View

Turnbaugh P, Hamady M, Yatsunenko T, Cantarel B, Duncan A, Ley R . A core gut microbiome in obese and lean twins. Nature. 2008; 457(7228):480-4. PMC: 2677729. DOI: 10.1038/nature07540. View

Tremaroli V, Backhed F . Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489(7415):242-9. DOI: 10.1038/nature11552. View

Pathak G, Silzer T, Sun J, Zhou Z, Daniel A, Johnson L . Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities. J Alzheimers Dis. 2019; 72(3):733-749. DOI: 10.3233/JAD-190634. View

Claesson M, Cusack S, OSullivan O, Greene-Diniz R, de Weerd H, Flannery E . Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4586-91. PMC: 3063589. DOI: 10.1073/pnas.1000097107. View

Mirzayi C, Renson A, Zohra F, Elsafoury S, Geistlinger L, Kasselman L . Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021; 27(11):1885-1892. PMC: 9105086. DOI: 10.1038/s41591-021-01552-x. View

10.

Meneilly G, Tessier D . Diabetes, Dementia and Hypoglycemia. Can J Diabetes. 2016; 40(1):73-6. DOI: 10.1016/j.jcjd.2015.09.006. View

11.

Guzman-Castaneda S, Ortega-Vega E, de la Cuesta-Zuluaga J, Velasquez-Mejia E, Rojas W, Bedoya G . Gut microbiota composition explains more variance in the host cardiometabolic risk than genetic ancestry. Gut Microbes. 2019; 11(2):191-204. PMC: 7053924. DOI: 10.1080/19490976.2019.1634416. View

12.

Stadlbauer V, Engertsberger L, Komarova I, Feldbacher N, Leber B, Pichler G . Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. BMC Geriatr. 2020; 20(1):248. PMC: 7372911. DOI: 10.1186/s12877-020-01644-2. View

13.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

14.

Sherwin E, Bordenstein S, Quinn J, Dinan T, Cryan J . Microbiota and the social brain. Science. 2019; 366(6465). DOI: 10.1126/science.aar2016. View

15.

Mozaffarian D, Hao T, Rimm E, Willett W, Hu F . Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011; 364(25):2392-404. PMC: 3151731. DOI: 10.1056/NEJMoa1014296. View

16.

Umpierrez G, Gonzalez A, Umpierrez D, Pimentel D . Diabetes mellitus in the Hispanic/Latino population: an increasing health care challenge in the United States. Am J Med Sci. 2007; 334(4):274-82. DOI: 10.1097/MAJ.0b013e3180a6efe3. View

17.

Clemente J, Ursell L, Parfrey L, Knight R . The impact of the gut microbiota on human health: an integrative view. Cell. 2012; 148(6):1258-70. PMC: 5050011. DOI: 10.1016/j.cell.2012.01.035. View

18.

Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

19.

Johnson L, Large S, Izurieta Munoz H, Hall J, OBryant S . Vascular Depression and Cognition in Mexican Americans. Dement Geriatr Cogn Disord. 2019; 47(1-2):68-78. DOI: 10.1159/000494272. View

20.

Johnson L, Gamboa A, Vintimilla R, Cheatwood A, Grant A, Trivedi A . Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans. J Alzheimers Dis. 2015; 47(1):129-36. DOI: 10.3233/JAD-142907. View